Key statistics
As of last trade, Rigel Pharmaceuticals Inc (RIGL:NSQ) traded at 33.40, 115.45% above the 52 week low of 15.50 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 34.12 |
|---|---|
| High | 35.00 |
| Low | 32.76 |
| Bid | 33.24 |
| Offer | 33.55 |
| Previous close | 34.62 |
| Average volume | 330.64k |
|---|---|
| Shares outstanding | 18.15m |
| Free float | 17.58m |
| P/E (TTM) | 5.61 |
| Market cap | 628.40m USD |
| EPS (TTM) | 6.17 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 19:12 GMT.
More ▼
- Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update
- Rigel Appoints Michael P. Miller to the Board of Directors
- Rigel Provides Business Update and 2026 Outlook
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
More ▼
